{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:30:55Z","timestamp":1770103855950,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tokyo Medical University"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.braindev.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T17:31:20Z","timestamp":1587663080000},"page":"523-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine"],"prefix":"10.1016","volume":"42","author":[{"given":"Gaku","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soken","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Morichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Oana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shonosuke","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nishimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.04.002_b0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.112.1.e1","article-title":"Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses","volume":"112","author":"Powers","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2020.04.002_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/head.12810","article-title":"The Childhood and Adolescent Migraine Prevention (CHAMP) study: a report on baseline characteristics of participants","volume":"56","author":"Powers","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2020.04.002_b0015","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2020.04.002_b0020","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","article-title":"Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society","volume":"63","author":"Lewis","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2020.04.002_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1610384","article-title":"Trial of amitriptyline, topiramate, and placebo for pediatric migraine","volume":"376","author":"Powers","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2020.04.002_b0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaneurol.2018.0046","article-title":"The changing landscape of pediatric migraine therapy: a review","volume":"75","author":"Patterson-Gentile","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2020.04.002_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11916-018-0692-6","article-title":"The evidence for the role of nutraceuticals in the management of pediatric migraine: a review","volume":"22","author":"Orr","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.braindev.2020.04.002_b0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-2982.1994.1405328.x","article-title":"High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study","volume":"14","author":"Schoenen","year":"1994","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2020.04.002_b0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.50.2.466","article-title":"Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial","volume":"50","author":"Schoenen","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2020.04.002_b0050","first-page":"1344","article-title":"Effectiveness of vitamin B2 versus sodium valproate in migraine prophylaxis: a randomized clinical trial","volume":"7","author":"Rahimdel","year":"2015","journal-title":"Electron Physician"},{"key":"10.1016\/j.braindev.2020.04.002_b0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1468-1331.2004.00813.x","article-title":"High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre","volume":"11","author":"Boehnke","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.braindev.2020.04.002_b0060","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/0333102410394675","article-title":"31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients","volume":"31","author":"Reyngoudt","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2020.04.002_b0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1212\/WNL.42.6.1209","article-title":"Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura","volume":"42","author":"Barbiroli","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2020.04.002_b0070","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0000000000000436","article-title":"Migraine and magnetic resonance spectroscopy: a systematic review","volume":"30","author":"Younis","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.braindev.2020.04.002_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1526-4610.2011.01847.x","article-title":"Nutraceuticals and headache: the biological basis","volume":"51","author":"Taylor","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2020.04.002_b0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fneur.2017.00333","article-title":"Riboflavin has neuroprotective potential: focus on Parkinson's disease and migraine","volume":"8","author":"Marashly","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2020.04.002_b0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.14238\/pi52.3.2012.132-7","article-title":"Riboflavin as migraine prophylaxis in adolescents","volume":"52","author":"Athaillah","year":"2012","journal-title":"Paediatr Indones"},{"key":"10.1016\/j.braindev.2020.04.002_b0090","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.19082\/6279","article-title":"Prophylactic effect of riboflavin on pediatric migraine: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Talebian","year":"2018","journal-title":"Electron Physician"},{"key":"10.1016\/j.braindev.2020.04.002_b0095","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/0883073808318053","article-title":"High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial","volume":"23","author":"MacLennan","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2020.04.002_b0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1177\/0333102410365106","article-title":"Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial","volume":"30","author":"Bruijn","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2020.04.002_b0105","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache S. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629\u2013808.","DOI":"10.1177\/0333102413485658"},{"key":"10.1016\/j.braindev.2020.04.002_b0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10194-009-0142-2","article-title":"Riboflavin prophylaxis in pediatric and adolescent migraine","volume":"10","author":"Condo","year":"2009","journal-title":"J Headache Pain"},{"key":"10.1016\/j.braindev.2020.04.002_b0115","first-page":"223","article-title":"Oral riboflavin versus oral propranolol in migraine prophylaxis: an open label randomized controlled trial","volume":"16","author":"Nambiar","year":"2011","journal-title":"Neurol Asia"},{"key":"10.1016\/j.braindev.2020.04.002_b0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1526-4610.2004.04170.x","article-title":"A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial","volume":"44","author":"Maizels","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2020.04.002_b0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejpain.2007.03.002","article-title":"Placebo response in the prophylaxis of migraine: a meta-analysis","volume":"12","author":"Macedo","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.braindev.2020.04.002_b0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ajcn\/63.1.54","article-title":"Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans","volume":"63","author":"Zempleni","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.braindev.2020.04.002_b0135","unstructured":"Institute of Medicine Committee on Use of Dietary Reference Intakes in Nutrition L. Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification. Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification. Washington (DC): National Academies Press (US) Copyright 2003 by the National Academy of Sciences. All rights reserved.; 2003."},{"key":"10.1016\/j.braindev.2020.04.002_b0140","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3945\/an.116.012716","article-title":"Riboflavin","volume":"7","author":"Pinto","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/j.braindev.2020.04.002_b0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1526-4610.2005.05050.x","article-title":"The placebo responder rate in children and adolescents","volume":"45","author":"Lewis","year":"2005","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2020.04.002_b0150","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2008-0642","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17\u00a0years of age","volume":"123","author":"Lewis","year":"2009","journal-title":"Pediatrics"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420301212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420301212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:57Z","timestamp":1759952937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420301212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0387760420301212"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.04.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}